JW 55
Cell-permeable, reversible tankyrase 1 (PARP5a) and tankyrase 2 (PARP5b) inhibitor. Also inhibits the β-catenin mediated canonical Wnt pathway
Product Specifications
Background
Inhibitor of the PARP domain of tankyrase 1 and 2 (TNKS1/2) . Activity results in stabilization of Axin2 and increased degradation of β-catenin; inhibits the β-catenin signaling pathway. Also shown to decrease canonical Wnt signaling in SW480 and HCT-15 colon carcinoma cell lines; reduces cell cycle progression and proliferation in SW480 cells in vitro.
CAS Number
664993-53-7
Purity
≥ 98% by HPLC
Solubility
Soluble in DMSO
Molecular Formula
C25H26N2O5
Shipping Conditions
Room Temperature (continental US) or Gel Packs
Storage Conditions
Store at or below +4°C. Solid form is stable at least 12 months from date of receipt, when stored as directed.
Calculated Molecular Weight
434.5 Da
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1321336-01 0.5 mg (E-Coli)
Recombinant Human CMRF35-like molecule 9 (CD300LG), partial
Sign In for Pricing
View Details 
MBS1321336-02 0.05 mg (Baculovirus)
Recombinant Human CMRF35-like molecule 9 (CD300LG), partial
Sign In for Pricing
View Details MBS1321336-03 0.5 mg (Yeast)
Recombinant Human CMRF35-like molecule 9 (CD300LG), partial
Sign In for Pricing
View Details MBS1321336-04 0.05 mg (Mammalian-Cell)
Recombinant Human CMRF35-like molecule 9 (CD300LG), partial
Sign In for Pricing
View Details 
MBS1321336-05 1 mg (E-Coli)
Recombinant Human CMRF35-like molecule 9 (CD300LG), partial
Sign In for Pricing
View Details